EW vs ULS · P/E 47, rev $1.39B vs P/E 55, rev $2.87B
Edwards Lifesciences Corp (EW) versus UL Solutions Inc. (ULS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
UL Solutions Inc. (ULS) is a specialty business services company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ULS revenue for 2024-12-31 was $2.87B. Net income was $345.0M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
Not investment advice. Open the EW and ULS stock pages for the full models.
Not investment advice.